Open Beta
MetriLume

US marketsNUVB

SEC-sourced researchBeta

NUVB

Nuvation Bio Inc.

Company comparison ↗

Data passport

CIK
0001811063
Exchange
NYSE
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Mar 2, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 7,873,000.0000 USD; December 2025: 62,902,000.0000 USD62.9M USD0 USD0December 2024December 2025
NUVB · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20247,873,000.0000Mar 2, 2026
December 202562,902,000.0000Mar 2, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202562,902,000.0000-204,627,000.0000-173,427,000.0000594,822,000.0000289,106,000.0000Mar 2, 2026
December 20247,873,000.0000-567,939,000.0000-130,413,000.0000540,626,000.000076,838,000.0000Mar 2, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$62.9MDecember 2025Mar 2, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$7.87MDecember 2024Mar 2, 202610-K
Net incomeNetIncomeLoss-$204.63MDecember 2025Mar 2, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$173.43MDecember 2025Mar 2, 202610-K
Total assetsAssets$594.82MDecember 2025Mar 2, 202610-K
Total liabilitiesLiabilities$289.11MDecember 2025Mar 2, 202610-K

New filings

Explore methodology ↗